Welcome to BioSeeker Group!

Line of Treatment

In this section you will find Therapeutics Line of Treatment market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.

5 Item(s)

per page

Set Ascending Direction
  1. Vascular Targeting Agents: Emerging Competitors

    $1,950.00
    Published by BioSeeker Group on Feb 8th, 2005
    An update on the most recent advances made for vascular targeting agents that are now entering an exciting stage of development. Learn More

  2. Strategic Outlook on Protein Kinase Inhibitors in Oncology

    $1,950.00
    Published by BioSeeker Group on Feb 20th, 2006
    A strategic outlook on protein kinase inhibitors in oncology. Including targets, indictions and competitive assessment. Learn More

  3. Protein Kinase Inhibitors in Oncology Drug Pipeline Update

    $2,250.00
    Published by BioSeeker Group on Aug 4th, 2016
    BioSeeker Group have identified 462 companies plus partners who are today developing 831 PKI drugs in 2912 developmental projects in cancer across 296 different targets. In addition, there are 5 suspended drugs and another 459 drugs where development has been ceased. Learn More

  4. New Concepts in Cancer Therapeutics

    $2,450.00
    Published by BioSeeker Group on Dec 30th, 2005
    There are, at present, ten times more anticancer drugs being tested in clinical trials than there were 20 years ago. Many of the new classes of agents.... Learn More

  5. Apoptosis: Promise or deception?

    $1,950.00
    Published by BioSeeker Group on May 7th, 2005
    In this publication, BioSeeker Group analyzes the latest progress made for 25 drug candidates targeting the cell death pathway, apoptosis. Additionally, more early stage candidates are also under investigation, which brings the total number of companies interested in this field to around 40. Learn More

5 Item(s)

per page

Set Ascending Direction